Invention Grant
US08829052B2 Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
有权
N-（芳基氨基）磺酰胺的衍生物作为MEK的抑制剂
- Patent Title: Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
- Patent Title (中): N-（芳基氨基）磺酰胺的衍生物作为MEK的抑制剂
-
Application No.: US13243368Application Date: 2011-09-23
-
Publication No.: US08829052B2Publication Date: 2014-09-09
- Inventor: Andreas Maderna , Jean-Michel Vernier , Dinesh Barawkar , Varaprasad Chamakura , Hassan El Abdellaoul , Zhi Hong
- Applicant: Andreas Maderna , Jean-Michel Vernier , Dinesh Barawkar , Varaprasad Chamakura , Hassan El Abdellaoul , Zhi Hong
- Applicant Address: US CA San Diego
- Assignee: Ardea Biosciences, Inc.
- Current Assignee: Ardea Biosciences, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Millen, White, Zelano & Branigan, P.C.
- Main IPC: A61K31/18
- IPC: A61K31/18 ; C07C311/14
Abstract:
This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
Public/Granted literature
- US20120022076A1 DERIVATIVES OF N-(ARYLAMINO)SULFONAMIDES AS INHIBITORS OF MEK Public/Granted day:2012-01-26
Information query
